by Gabriel Oke | Nov 8, 2024 | Uncategorized
Antimicrobial resistance (AMR) presents a looming threat to healthcare systems worldwide, with the potential to render routine treatments ineffective and even minor infections life-threatening. Yui Kohno, a manager at the Health and Global Policy Institute (HGPI) in...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, particularly with the rise of multidrug-resistant TB (MDR-TB). For years, the standard approach to treating TB has followed a “one-size-fits-all” regimen, but that may soon change,...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Matthias Eberl, a professor of translational immunology at Cardiff University (Wales, UK) and Michael Mosha, a dedicated pharmacist and researcher in Dodoma (Tanzania), are joining forces to tackle the global issue of antimicrobial resistance (AMR) through science,...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Dr. Jonas R. Henriksen, who holds a PhD in physical chemistry from the Technical University of Denmark, is making significant progress in the fields of drug delivery and antimicrobial resistance (AMR). His career began in biophysics, providing a strong scientific...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
In the fight against antimicrobial resistance (AMR), groundbreaking research is crucial for developing new strategies to combat resistant bacteria. Two scientists, Fredrik Westerlund and Hana Sipova-Jungova, are bringing their unique expertise and innovative...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Antibiotic resistance is one of the most significant global health threats today, disproportionately affecting marginalised communities that often lack access to reliable healthcare information. In response, Dr. Ripudaman Singh Minhas, a Developmental Pediatrician at...
